<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967444</url>
  </required_header>
  <id_info>
    <org_study_id>05DF1807</org_study_id>
    <nct_id>NCT03967444</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Satisfaction After Treatment With Kysse</brief_title>
  <official_title>Post Marketing Study to Evaluate Lip Augmentation &amp; Satisfaction With Restylane Kysse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction
      after treatment with Kysse.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 29, 2019</start_date>
  <completion_date type="Actual">September 18, 2019</completion_date>
  <primary_completion_date type="Actual">September 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aesthetic improvement</measure>
    <time_frame>8 weeks after last treatment</time_frame>
    <description>Using the Global Aesthetic Improvement Scale (GAIS).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Lip Augmentation</condition>
  <arm_group>
    <arm_group_label>Restylane Kysse</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hyaluronic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restylane Kysse with other HA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hyaluronic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>Injectable gel for lip augmentation</description>
    <arm_group_label>Restylane Kysse</arm_group_label>
    <other_name>Restylane Kysse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>Injectable gel. Lip Augmentation and other wrinkles/folds</description>
    <arm_group_label>Restylane Kysse with other HA</arm_group_label>
    <other_name>Restylane Kysse with other Restylane products</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed and dated informed consent to participate in the study

          -  Adult women and men who intend to undergo lip augmentation

        Exclusion Criteria:

          -  Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local
             anesthetics

          -  Subjects with a previous implant other than HA in or near the intended treatment site

          -  Participation in any other clinical study within three (3) months before treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Q-Med AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Galderma Study Site</name>
      <address>
        <city>Montr√©al</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galderma Study Site</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>May 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

